首页> 外文OA文献 >Reassessing the effects of continuous positive airway pressure (CPAP) on arterial stiffness and peripheral blood derived CD34+ progenitor cells in subjects with sleep apnea
【2h】

Reassessing the effects of continuous positive airway pressure (CPAP) on arterial stiffness and peripheral blood derived CD34+ progenitor cells in subjects with sleep apnea

机译:重新评估连续正气道压力(CPAP)对睡眠呼吸暂停患者动脉僵硬和外周血衍生CD34 +祖细胞的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Abstract Background Obstructive sleep apnea (OSA) is an independent risk factor for cardiovascular diseases (CVD) and vascular health. Peripheral blood-derived CD34+ progenitor cells have been used as biomarker for CVD risk and may play a similar role in OSA and CVD risk assessment. Although there are some controversial results in the literature, OSA patients may have a reduction in the number and function of CD34+ cells. The damages promoted by OSA in CD34+ cells may lead to an increase in endothelial oxidative stress and endothelial inflammation which may lead to a reduced endothelial repair capacity. In this study, we explored the effect of continuous positive airway pressure (CPAP) on peripheral blood-derived CD34+ cells and arterial stiffness (another predictor of endothelial health and CVD risk) in OSA patients. Methods and results Nine overweight and obese subjects without prediabetes or diabetes were recruited. Eight out of nine subjects had moderate to severe degree of OSA. CD34+ cells were isolated from peripheral blood. Number and function of these cells were monitored before and after 3 months of treatment with CPAP. No significant changes were observed in the number of CD34+ cells, CFU-Hill’s colony formation unit (CFU) count or migratory response to the chemotactic factor SDF-1a after CPAP use. However, CXCR4 mRNA expression significantly increased by 2.2-fold indicating that CPAP may have a positive effect on SDF1a receptor (CXCR4), thereby improving migration of CD34+ cells mediated by SDF1a after the 3 month period. Interestingly, in clinical arena our results showed a reduction of pulse wave velocity (an established parameter of arterial stiffness) following CPAP therapy. Conclusions Our findings suggest that 3-month CPAP intervention does not show statistical significant increase in CD34+ cell number and function, in mostly moderate to severe OSA subjects; however, it did demonstrate a positive trend. CPAP therapy, did help improve arterial stiffness parameter.
机译:摘要背景阻塞性睡眠呼吸暂停(OSA)是心血管疾病(CVD)和血管健康的独立危险因素。外周血来源的CD34 +祖细胞已被用来作为生物标志物用于心血管疾病的风险,并可能在OSA和心血管疾病的风险评估类似的作用。虽然有在文献中一些有争议的结果,OSA患者可能有在CD34 +细胞的数量和功能的降低。通过OSA中的CD34 +细胞促进了损害可能导致增加的内皮氧化应激和炎症的内皮,这可能导致降低的内皮修复能力。在这项研究中,我们探讨的外周血来源的CD34 +细胞和动脉硬度在OSA患者(内皮健康和CVD风险的另一个预测器)持续气道正压(CPAP)的影响。方法和结果九超重和肥胖者没有糖尿病前期或糖尿病被招募。八出九门学科有中度到OSA的严重程度。 CD34 +细胞从外周血中分离。这些细胞的数量和功能前,后3个月的治疗用CPAP进行了监测。在CD34 +细胞的数量没有观察到显著变化,CFU-Hill的集落形成单元(CFU)计数或CPAP使用后,将趋化因子SDF-1α迁移反应。然而,CXCR4 mRNA表达显著增加2.2倍,表明CPAP可能对SDF1a受体(CXCR4)有积极的作用,从而提高了3个月时间后由SDF1a介导的CD34 +细胞的迁移。有趣的是,在临床领域我们的结果表明:CPAP治疗以下的减小脉搏波速度(动脉僵硬度的建立的参数)。结论:我们的研究结果表明,3个月的CPAP干预不显示在CD34 +细胞数量和功能的统计显著增加,大多是中度至重度OSA患者;然而,它确实表现出积极的趋势。 CPAP治疗,也有助于改善动脉僵硬度参数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号